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Abstract
Objective—An inverse relationship between blood pressure and cognitive function has been
found in adults, but limited data are available in adolescents and young adults. We examined the
prospective relation between blood pressure and cognitive function in adolescence.
Methods—We examined the association between BP measured at the ages of 12–15 years in
school surveys and cognitive endpoints measured in the Seychelles Child Development Study at
ages 17 (n=407) and 19 (n=429) years, respectively. We evaluated multiple domains of cognition
based on subtests of the Cambridge Neurological Test Automated Battery (CANTAB), the
Woodcock Johnson Test of Scholastic Achievement (WJTA), the Finger Tapping test (FT) and the
Kaufman Brief Intelligence Test (K-BIT). We used age-, sex- and height-specific z-scores of
systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean arterial pressure (MAP).
Results—Six out of the 21 cognitive endpoints tested were associated with BP. However, none
of these associations were found to hold for both males and females or for different subtests within
the same neurodevelopmental domain or for both SBP and DBP. Most of these associations
disappeared when analyses were adjusted for selected potential confounding factors such as socio-
economic status, birth weight, gestational age, body mass index, alcohol consumption, blood
glucose, and total n-3 and n-6 polyunsaturated fats.
Conclusions—Our findings do not support a consistent association between BP and subsequent
performance on tests assessing various cognitive domains in adolescents.
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INTRODUCTION
Hypertension in adolescence is increasingly recognized as a health problem, which may
affect long-term health and development. A recent narrative review mainly based on
evidence from adult studies concluded that chronic hypertension in children could result in
learning disabilities and deficiencies in executive function [1]. However, we are aware of
only a few observational studies on the association between blood pressure (BP) and
cognitive function in young persons that support this possibility [2–5]. Therefore, the
relationship between cognitive function and BP in adolescence is still unclear.
As shown in a recent review [6], the association between hypertension and cognition has
been well recognized and investigated for decades in adults. While the overall consensus
based on cross-sectional and prospective studies is that there is a clinically significant
cognitive decline with hypertension, the shape of the association has been described as
linear[7–9], J-shaped [10] or U-shaped [11] in middle-aged and elderly adults. . Data from
randomized controlled trials could provide convincing evidence. However, only a few trials
have examined cognitive function in response to BP reduction and none was conducted
among youth. While cognitive function improved in response to blood pressure lowering
medication in a trial among adults over 69 years [12], a recent meta-analysis of nine
placebo-controlled trials among middle-aged and elderly individuals showed no reduction in
the overall risk of dementia and some differences in further sub-group analysis according to
medication type [13]. Although the mechanisms relating BP to cognitive function in both
adolescence and young adults are still largely unclear, in older adults both hypotension and
hypertension are known to be associated with disruption in neurovascular coupling leading
to decreased vascular reserve capacity, cognitive decline, and dementia [15].
Given that the association between BP and cognitive function may be modified by age,
further evaluation of this relationship is needed at all ages, especially in young persons.
Studying the association between BP and cognitive function in youth has the advantage of
being less biased by concurrent effects of age-related co-morbid conditions and medications,
which typically occur at older ages. In this study, we examined whether BP, measured at the
ages of 12 and 15 years in school surveys, was associated with cognitive function assessed
by a broad battery of cognitive outcomes measured at ages 17 and 19 years in the Seychelles
Child Development Study (SCDS).
METHODS
Study population
The SCDS is a prospective cohort study initiated in 1989–90 to assess the association
between prenatal exposure to mercury from fish consumption during pregnancy and
subsequent child development. Details of this study have been previously described [16] and
data showed no consistent association between pre-natal exposure to mercury and the later
development in childhood of either cognitive function [17] or blood pressure [18]. The
cohort represents about 50% of all births during the enrollment period. All children who
were 3±1 month of age were invited to participate and those who accepted were enrolled. Of
the 779 Seychellois infants originally enrolled, 705 subjects were eligible for evaluation
after exclusion of 74 participants because of lack of prenatal exposure data, the presence of
medical conditions that might affect development, or withdrawal from the study. Since
cognitive test requires color vision, another 7 participants (total n= 698) were excluded from
the analysis.
As part of the study design, the participants completed a comprehensive battery of cognitive
tests assessing learning, memory, attention and academic performance at age 17 years and of
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motor speed and control, verbal and non-verbal intelligence at age 19 years. Informed
consent was obtained from the parents or caregivers of the participants until age 17 years
and from the participants at age 19 years.
Data on BP were available from a routine school-based surveillance program of all students
in the 7th and 10th grades aged 12 and 15 years respectively. The survey was conducted in
all public and private schools in Seychelles under the auspices of the Ministry of Health and
the Ministry of Education. We linked these school-based BP data with the cognitive
outcomes assessed within the SCDS based on the national identification number that is
available for all Seychelles citizens. The study protocol was approved by the human subjects
review boards at both the University of Rochester, USA, and in the Republic of Seychelles.
Study procedures and measurements
Cognitive measures—At age 17 years, participants in the SCDS were evaluated using a
battery of neuropsychological tests (Supplementary Table 1). These tests included the
Cambridge Neurological Test Automated Battery (CANTAB), which assessed learning,
attention and memory, and the Woodcock Johnson Tests of Achievement (WJTA), which
assessed academic performance. At age 19 years, participants completed the Finger Tapping
(FT) test which assessed motor speed and control, and the Kaufman Brief Intelligence Test
(K-BIT), which assessed verbal and non-verbal intelligence. These tests have been well
validated and have been used extensively in previous epidemiological studies [20, 21] and in
the Seychelles participants [22, 23]. The tests were translated into the Creole language and
used after having been carefully piloted [16].
Blood pressure measurements—Methods used for BP measurement within the school
screening program and selected results have been described previously [24]. Briefly, BP was
measured by trained school nurses in all students of all schools at ages 12 and 15 years.
Readings were performed using a validated oscillometric automated device (Omron M5,
Omron Healthcare Europe BV, The Netherlands). The children were in the sitting position,
after a rest of at least 5 minutes, and cuff size was adapted to the arm circumference. Two
BP readings were taken one minute apart at each visit and the average of the two values was
computed at both 12 and 15 years of age. Z scores of both systolic BP (SBP) and diastolic
BP (DBP) specific for age, sex and height were generated using standard guidelines [25].
We also generated an index for mean arterial BP (MAP) using the formula: DBP + 1/3 ×
(SBP-DBP)) [26].
Covariates—We adjusted analyses for variables known or presumed to be associated with
BP and/or cognitive function [4, 27–30]. Covariates included birth weight, gestational age,
socio-economic status, alcohol consumption (measured at age 19 years), body mass index
(BMI, derived from the average of measurements made at the ages of 12 and 15 years),
blood glucose (measured at age 19 years), and total n-3 and n-6 polyunsaturated fats (PUFA)
(measured at age 19 years).
Information on birth weight and gestational age was available from birth records.
Socioeconomic status was measured as maternal Hollingshead score obtained at age 17
years [31]. This score is based on maternal occupational and educational characteristics. The
subjects alcohol consumption was determined based on the self-reported number of days
with one or more drinks in the past month (none, 1–2 days and 3 days and above). Body
mass index (BMI) was calculated as weight (kg) divided by height (meters) squared. Weight
was measured using a precision electronic scale (Seca 870, Hamburg, Germany) and height
was measured with a fixed stadiometer (Seca 208). Fasting blood glucose (FBG) was
measured on venous plasma using a Glycotronic® C reflectometer (Macherey-Nagel, Düren,
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Germany). We used total n-3 (combining docosahexaenoic acid + eicosapentaenoic acid +
alpha-linolenic acid) and total n-6 (combining arachidonic acid + linoleic acid) as measures
of polyunsaturated fatty acid concentration in plasma; the details of measurements have
been previously described [32].
Statistical analysis
With regards to baseline variables, we calculated the mean and standard deviation (SD) for
continuous variables and percentages for categorical variables. Because BP and cognitive
function differ by sex, analyses were performed separately in males and in females. We used
the t-test to test for differences in continuous variables between males and females and the
chi-square test for categorical covariates. We used Spearman rank correlation coefficients to
describe the correlations between the different subtests of cognitive function.
The main aim of this study was to examine whether BP (SBP, DBP and MAP) at aged 12–
15 years was associated with i) CANTAB and WJTA outcomes at 17 years and ii) FT and
K-BIT at 19 years as the dependent variables. We used z-scores for BP because normal
values of BP vary by age, height and sex in children and adolescents. Hence the “crude”
associations between BP and cognitive function tests are inherently adjusted for sex, age and
height. Of the 698 participants of the SCDS examined around birth, data were available for
580 (83%) participants for BP at age 12–15 years; for 518(74%) /453 (65%) participants for
CANTAB/WJTA at age 17 years; and for 451 (65%) participants for FT/KBIT at age 19
years. Hence, for the present analysis complete data on BP and relevant cognitive tests were
available for 407 participants at age 17 years and 429 participants at age 19 years. We also
carried out multivariable analyses controlling for socio-economic status, birth weight,
gestational age, BMI (at age 12–15 years), alcohol consumption (at age 19 years), blood
glucose (at age 19 years), total n-3 and n-6 (at age19 years). The proportion of missing data
for the covariates ranged from 0.25% for alcohol consumption to 26.7% for socioeconomic
status. The multivariable analyses utilize data on available cases. Since sex differences in the
association between BP and cognition have been observed earlier [33], we included a
multiplicative interaction term between sex and BP indexes in the overall models. We report
the standardized regression coefficients (which express the change in the cognitive outcome
corresponding to a 1 SD increase in the respective BP index) to allow direct comparison of
the associations of BP indexes with different cognition tests. Regression diagnostics were
performed for all the analyses and appropriate transformation was made whenever the
residuals were not normally distributed. Transformations included: log transformation for
intra-extra dimensional shift (IED) total trials, IED pre-ED errors, paired associate learning
(PAL) total errors+1, RTI simple reaction time and rapid visual information processing
(RVP) total false alarms+1; square-root transformation for spatial working memory (SWM)
within errors and SWM total errors; and square transformation for letter-word identification.
Further, we split the sample into participants with values above and below the 75th
percentile both for BP indexes and cognitive functions and ran multiple logistic regression
analyses adjusting for the same co-variates. We used cutoffs of 75th percentile to ensure that
we had sufficient numbers in both the groups. Statistical tests were performed using Stata 11
(StataCorp, College Station, TX, USA). The significance level used for two-sided tests was
P < 0.05. The current study involved secondary analysis of data but the selection of co-
variates and the analytical models used were decided before running the analyses to
minimize spurious findings when examining a large number of associations. Nonetheless,
we also interpreted the findings after using the Bonferroni correction procedure to adjust for
multiple hypothesis testing (i.e. by setting statistical significance of the P value at 0.001
(0.05/21 endpoints).
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RESULTS
Table 1 summarizes selected demographic and clinical characteristics of the participants.
Differences between males and females were observed for some of the characteristics
including socio-economic status, alcohol consumption, birth weight, BMI and fasting
glucose.
The distribution of BP and cognitive outcomes in the participants is presented in Table 2.
Females had higher mean DBP while males had higher levels of SBP. With regards to the
cognitive outcomes, very few (7 out of 21 tested) of the test scores were different between
males and females. There was, however, no consistent difference between males and
females in their test scores across the remaining subtests within the same cognitive domains
except for FT (which only had 2 subtests).
Correlation coefficients between the different subtests of cognition ranged from 0.01
(between FT dominant hand and paired associate learning (PAL) total errors, WJTA letter-
word identification and math fluency) to moderately high correlation of 0.57 (between K-
BIT verbal scaled score and WJTA passage comprehension) and 0.79 (between WJTA
applied problems and calculation) (Supplementary Table 2). These correlations suggest
some degree of overlap between tests within and between domains of cognitive function.
The crude associations between BP z-scores and various domains of the CANTAB and
WJTA subtests at 17 years of age are presented in Table 3a. On the CANTAB we found
associations of paired associate learning (PAL) stages with SBP and MAP in females, rapid
visual information processing (RVP) total misses with DBP, spatial working memory
(SWM) with DBP and MAP in the overall sample. We did not observe any associations with
the other cognitive outcomes including the academic achievement indicators.
At age 19 years, we found FT test scores in the dominant hand to be inversely associated
with DBP while those in non-dominant hand to be positively associated with SBP in all
participants (Table 3b).
Results were not altered after adjusting for socio-economic status, birth weight, gestational
age, BMI, alcohol consumption, blood glucose, or total n-3 and n-6. (Supplementary Tables
3a and 3b). There were no significant sex interactions with any model. Similarly, using
logistic regression including those above and below 75th percentile (Supplementary Tables
4a and 4b) did not produce any consistent associations of BP with cognitive function and the
few significant associations present were not the same as those in the linear regressions. On
adjusting for multiple testing, the few significant associations that we observed in the
univariate and multi-variate regressions were no longer significant.
DISCUSSION
We found no consistent evidence of an association between BP measured in early
adolescence and cognitive outcomes measured in late adolescence. BP was associated with 3
of the 21 endpoints in the primary analysis, but after accounting for multiple testing there
were no associations present. These associations could have been due to chance, particularly
when one considers that the limited associations present were not consistent for both systolic
and diastolic BP, or for both males and females, or for different subtests measuring the same
neurodevelopmental domain. Therefore, our findings do not support a substantial and
consistent association of BP with cognitive function in adolescence.
In older adults, several physiologic mechanisms, including atherosclerotic and
hemodynamic processes, have been postulated to link BP to diminished cognitive function.
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Small vessel disease is associated with impairment of cerebral blood flow and breakdown of
the blood-brain barrier [34]. These hemodynamic conditions related to hypertension or even
hypotension (e.g. excessive BP reduction) may induce cerebral hypoperfusion and result in
disruption of neuronal activity and subsequent neurodegenerative processes characterized by
white matter lesions visible with magnetic resonance imaging [35]. Studies have shown that
white matter lesions are closely correlated with both hypertension [36] and poorer cognitive
functions [37].
Although a role of BP on cognitive function was hypothesized in young persons [1], few
studies have examined the association between BP and cognitive function in this age group.
This question is relevant in view of adverse associations found among middle aged adults
[38] and considering that cognitive function improved with antihypertensive treatment in
middle-aged hypertensive adults [39]. A cross-sectional study conducted in a nationally-
representative sample of 5077 children aged 6–16 years in the US (NHANES III) found that
cognitive function (based on block design and digit span test scores of the Wechsler
Intelligence Scale for Children (WISC) and the Revised-WISC) decreased as SBP (but not
DBP) increased [4]. Similarly, a higher prevalence of learning disabilities (defined as a
subject having a current individualized education plan) was observed among hypertensive
(18%) as compared to non-hypertensive children (9%) in a small cross-sectional study of
201 children [2]. In contrast, Wharton and colleagues demonstrated that BP was associated
with enhanced cognition, as measured by two visuospatial attention tasks. However, high BP
was not associated with recognition memory performance in another smaller cross-sectional
study of 105 participants with a mean age of 19.3 years [5]. Of note, results of cross-
sectional studies may not distinguish if hypertension precedes or follows the measured
outcomes. For example, emotional stress or anxiety, as a result of impaired learning skills
due to cognitive impairment, could be a cause of elevated BP rather than elevated BP being
a cause of cognitive impairment [40].
Hence, our findings are partly in agreement with the study of Wharton and coworkers (who
observed no association between BP and memory performance) but contrast with results in
the NHANES III (which found an inverse association between an intelligence test and BP).
Although the NHANES III had a large sample, it assessed only intellectual function and
academic performance. It is important to note that the three studies showing either positive
or negative associations in youth used a cross-sectional design, while our findings are based
on longitudinal data. A possible explanation for the lack of association between BP and
cognition in adolescents in our study can be that some anticipated underlying mechanisms
(e.g. atherosclerotic changes and other age-related co-morbidities related to hypertension)
are unlikely to occur at this young age. As noted in a review, BP has to be severely elevated
for end-organ damages to occur in the central nervous system of hypertensive children [41].
It is also possible that mild to moderate elevation in BP may not be enough to trigger
manifestations of cognitive decline. Finally, duration of follow-up is an equally important
consideration. A recent review by Elias and colleague found that relations between
hypertension and cognition are more likely to be observed when the exposure to
hypertension precedes the outcome by as many as 10 to 20 years [6].
The presence of an association between BP and cognition in young subjects in earlier studies
may suggest that other mechanisms could underlie the development of cognitive impairment
in young adults or that associations are confounded by variables other than those considered
in our analyses. Increased cardiovascular or neuroendocrine reactivity and anxiety are some
of the hypotheses proposed to explain the putative associations between cognition and
hypertension in adolescents [42]. BP is a complex parameter and it is possible that
associations between BP and intelligence could be influenced by an accumulation of
experiences throughout life including birth history, dietary habits, family disruption etc. It
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could follow that these factors would need to be identified and considered in analytical
models. It is often difficult to assess whether BP is an independent risk factor or simply a
marker of other cardio-metabolic conditions. Hence, the association between BP and
cognition observed in some studies (as well as in our study) could be driven by other factors
which tend to co-exist with BP. For example, BP tends to interact with type 2 diabetes with
regards to cognitive function and hypertensive adults with diabetes are at greatest risk for
poor cognitive performance [43]. In our study, adjusting for a number of important
covariates did not alter the results.
Our study has several strengths including a fairly large sample size relative to most previous
studies in adolescents and adults, a detailed assessment of cognitive and academic tests, a
prospective design and information on a number of covariates known to influence the
associations. Our study also has some limitations. Firstly, the precision of our BP
measurements is limited since we relied on only 2 readings of BP at each of two visits at age
12 years and age 15 years (hence a total of 4 readings). However, the correlation between
BP at age 12 years and age 15 years (r=0.35 and 0.31 for SBP and DBP respectively) was
good and similar to other studies with the same length of follow-up [44], suggesting that BP
was adequately assessed in our study. Secondly, we used US references to assess age-, sex-
and height-adjusted BP. While these z-scores may need to be calibrated before they are used
in other populations, the ranking of BP among children is likely to be unaffected and the
associations we found with outcomes are likely to be valid. Thirdly, there has been some
attrition in the SCDS cohort with participation of 58% at age 17 and 61% at age 19 from the
initial cohort examined at birth. The reduction in the sample size is mainly due to two
reasons. Firstly, attrition could have arisen due to the long follow up of the SCDS cohort (at
age 17–19 years), possibly limited motivation of adolescents to participate in follow up
examinations (which could last up to two consecutive days), and possible unwillingness to
give blood (at age 19 years). Secondly, we used data on BP from a school-based surveillance
program conducted at age 12–15 years. In this routine school-based screening program,
students who were not present on the survey day were generally not traced and the screening
may not have been performed in some classes due to limited manpower. However, there was
no significant difference in baseline characteristics including birth weight, gestational age,
socio-economic status and clinical characteristics including BMI, glucose, total n-3 and n-6
measured at 19 years between subjects included and not included in the analysis (data not
shown), which suggests that our estimates are not biased because of missing data. Future
studies with a larger sample size, larger number of BP measurements including ambulatory
BP monitoring and more covariates assessed through the life course may be needed to
unravel the contribution and combinations of the many complex parameters that impact
cognitive function. Similarly, further analysis based on changes of both exposure and
outcome over time could provide additional insight to disentangle the effect of BP on
cognitive outcomes while analysis of changes in cognitive outcomes in relation to BP
lowering treatment in youth would provide more definite answers.
In conclusion, our findings do not support a consistent association between BP and cognitive
function during adolescence.
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